# Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease

> **NCT02484755** · PHASE2 · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 6 (estimated)

## Conditions studied

- Cushing's Disease
- Corticotrophin Adenoma

## Interventions

- **DRUG:** Gefitinib

## Key facts

- **NCT ID:** NCT02484755
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2015-09
- **Final completion:** —
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484755, "Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02484755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*